Replies to post #66578 on Blue Diamond Ventures Inc (BLDV)

[Walker]

Agree and disagree - agree on how fast it will hit a penny with that news, but also think there is other news just as big or bigger that can do the same.

Think ISRAEL!!!

[Kool Aid Man]

"...if AMS gains approval to produce, and if AMS gains financing to build out the 50,000 sq ft barn, and if both these events are announced simultane(ously)...then BLDV PPS hits ONE PENNY within THREE DAYS... "

As I understand it, AMS has to FIRST complete the $12 million build out of their grow facility first. Once the facility is inspected and approved they'd be given the OK begin growing. THEN they have to go through TWO full "grow cycles" -->>before<<-- being granted a full MMJ license by Canada. Presumably there would be further testing and approval needed on their MMJ products to make sure they're both safe and effective before sales to the public can begin.

All that represents a TON of costs BEFORE revenues start rolling in.

>>IF<< Alper can prove he has secured adequate financing from verifiably legitimate, deep pocketed investors --and reveals te full terms of those arrangements to shareholders-- then one can make an informed decision about this venture.

[JPS02]

Statement from Health Canada on Improving the Licensing of Production of Cannabis for Medical Purposes

Statements

From Health Canada

May 26, 2017 - Ottawa, ON - Health Canada

OTTAWA – Health Canada is introducing several improvements to its medical cannabis program that aim to streamline the application process for issuing production licenses and enable increased production under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

Health Canada has drawn on nearly four years of experience to identify measures that can be put in place to streamline licensing and enable increased production of cannabis. These measures will also help ensure that Health Canada’s approach to licensing and oversight continues to be aligned with the regulations, the existing evidence of risks to public health and safety, and its approach to other regulated sectors.

Effective immediately, Health Canada is implementing the following measures:

• Increasing the Department’s capacity to review and process applications.

• Undertaking some stages of the review of the application concurrently.

• Permitting licensed producers to manage production on the basis of their vault capacity.

• Authorizing longer validity periods for licences and security clearances in accordance with the regulations.

• Streamlining the review and approval of applications to modify or expand an existing production facility for licensed producers with a record of good compliance with the ACMPR.

Health Canada will continue to inspect all facilities before cultivation begins and before a licence to sell products to the public is issued. Henceforth, Health Canada will schedule this first inspection after it has determined an application meets the regulatory requirements and it has issued the licence to cultivate and once the producer is ready to initiate production in its facility. This approach will help provide successful applicants with a decision on their application as soon as possible while ensuring that all facilities are inspected as cultivation begins.

Licensed producers and applicants must continue to meet all of the requirements under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The ACMPR represents among the most robust frameworks in the world for ensuring effective control and regulation of cannabis for medical purposes. The ACMPR includes security and inventory control measures that help prevent diversion, as well as requirements for Good Production Practices that help provide individuals with access to quality-controlled cannabis for medical purposes. Since licensed production began in June 2013, licensed producers have established a solid record of compliance with the regulatory requirements and Health Canada will continue to ensure compliance through regular inspection.

In addition to the measures announced today, Health Canada has already dedicated additional resources to accelerate the processing of applications from individuals who are authorized to produce a limited amount of cannabis for their own medical purposes.

Health Canada will continue to work closely with patients, patient advocates and licensed producers to identify and act on opportunities to improve access to cannabis and service to Canadians.

Associated Links
Backgrounder - Improving the Licensing of Production of Cannabis for Medical Purposes

Contacts
Media Relations
Health Canada
613-957-2983

Public Inquiries
[phone]
1-866 225-0709

Source: https://www.canada.ca/en/health-canada/news/2017/05/statement_from_healthcanadaonimprovingthelicensingofproductionof.html

[JPS02]

Check out the following paragraph in stervc's post which I think is very powerful and insightful, therefore I broke up each sentence to better understand each of the important points stervc presented:

stervc's post: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132570308

1. AMS will pay the Funder back the $12 million plus interest from the Revenues to be generated.

2. AMS already have relationships with pharmaceutical companies as clientele in place to support their marijuana cultivation in Canada whom will buy product and products from AMS.

3. They also have huge plans for expansion in place.

4. After a year and since the AMS project is expected to be fully operational by then, AMS is then expected to exercise its right to refinance its operations by using their completed facility as collateral to remove the current Funder from the equation.

5. They will pay the Funder back its money with interest then AMS will become their own Funder by funding its own operations.

These important points that you present beg the question of the value of AMS to BLDV once the:

i) $12 million financing is approved;

ii) Health Canada approval to cultivate is received;

iii) Revenues start to be earned from cultivation operations; and,

iv) Expansion is completed in the future.

I think this question is important in regards to the positive impact on the BLDV pps given the non-dilutive acquisition of AMS that you pointed out in this post:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132347362

Thanks for sharing your insightful thoughts.

Go BLDV!

[tncurler]

If ur right (and I think u r), then with strong hands we should see a significant increase. That kind of news should flush Shorty!